Filing Details

Accession Number:
0001209191-22-054261
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-21 16:10:01
Reporting Period:
2022-10-19
Accepted Time:
2022-10-21 16:10:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1720580 Adicet Bio Inc. ACET Pharmaceutical Preparations (2834) 813305277
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1886986 Blake Aftab C/O Adicet Bio, Inc.
200 Berkeley Street, 19Th Floor
Boston MA 02116
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-10-19 8,067 $16.27 35,176 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.01 to $16.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.